DISEASE INDICATIONS: Hereditary angioedema (HAE)
MANUFACTURER: Shire Pharmaceuticals
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Takhzyro (lanadelumab) is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. HAE is a rare genetic disorder that causes episodes of swelling in the face, throat, abdomen, hands, and feet. These episodes can be life-threatening.
